Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Holley Pharmaceuticals Loses Copyright Infringement Case

This article was originally published in PharmAsia News

Executive Summary

Chongqing Intermediate People's Court has declared Holley Pharmaceuticals (Chongqing) guilty of infringing on Chongqing Jianqiao Pharmaceutical Development's copyright. It ordered HolleyPharm to stop production of its Duo-Cotecxin (dihydroartemisinin) tablets immediately and destroy any drugs produced before the ruling, as well as pay Chongqing Jianqiao 1 yuan for economic losses. HolleyPharm has indicated it will appeal to Chongqing Higher People's Court but states that there will be little impact on its overseas drug production and sales even if the future ruling remains the same. According to the company, Duo-Cotecxin revenue in China makes up only 1 percent of its total income. (Click here for more - Chinese Language)

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts